These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1577063

  • 1. Sublytic complement attack protects tumor cells from lytic doses of antibody and complement.
    Reiter Y, Ciobotariu A, Fishelson Z.
    Eur J Immunol; 1992 May; 22(5):1207-13. PubMed ID: 1577063
    [Abstract] [Full Text] [Related]

  • 2. Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis.
    Reiter Y, Ciobotariu A, Jones J, Morgan BP, Fishelson Z.
    J Immunol; 1995 Aug 15; 155(4):2203-10. PubMed ID: 7636268
    [Abstract] [Full Text] [Related]

  • 3. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW, Kadlec JV, Petrella EC, Bredehorst R, Vogel CW.
    Cancer Res; 1993 Feb 01; 53(3):592-9. PubMed ID: 8425193
    [Abstract] [Full Text] [Related]

  • 4. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI, Jenkins DE, Leddy JP.
    J Immunol; 1985 Jan 01; 134(1):506-11. PubMed ID: 3964820
    [Abstract] [Full Text] [Related]

  • 5. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
    Kochi SK, Johnson RC, Dalmasso AP.
    J Immunol; 1991 Jun 01; 146(11):3964-70. PubMed ID: 2033266
    [Abstract] [Full Text] [Related]

  • 6. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
    Matsumoto M, Sugita Y, Seya T.
    Eur J Immunol; 1991 Aug 01; 21(8):1787-92. PubMed ID: 1714391
    [Abstract] [Full Text] [Related]

  • 7. Complement membrane attack complexes induce in human leukemic cells rapid expression of large proteins (L-CIP).
    Reiter Y, Fishelson Z.
    Mol Immunol; 1992 Jun 01; 29(6):771-81. PubMed ID: 1603095
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA, Zhao J, Ninomiya H, Sims PJ.
    J Immunol; 1991 Apr 01; 146(7):2345-51. PubMed ID: 1706395
    [Abstract] [Full Text] [Related]

  • 9. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
    Shin ML, Hänsch G, Hu VW, Nicholson-Weller A.
    J Immunol; 1986 Mar 01; 136(5):1777-82. PubMed ID: 2419414
    [Abstract] [Full Text] [Related]

  • 10. Membrane vesiculation protects erythrocytes from destruction by complement.
    Iida K, Whitlow MB, Nussenzweig V.
    J Immunol; 1991 Oct 15; 147(8):2638-42. PubMed ID: 1918984
    [Abstract] [Full Text] [Related]

  • 11. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov 15; 131(5):2563-9. PubMed ID: 6355296
    [Abstract] [Full Text] [Related]

  • 12. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
    Brahmi Z, Csipo I, Bochan MR, Su B, Montel AH, Morse PA.
    Nat Immun; 1995 Sep 15; 14(5-6):271-85. PubMed ID: 8933821
    [Abstract] [Full Text] [Related]

  • 13. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
    Hänsch GM, Hammer CH, Mayer MM, Shin ML.
    J Immunol; 1981 Sep 15; 127(3):999-1002. PubMed ID: 6911149
    [Abstract] [Full Text] [Related]

  • 14. Heymann antibodies induce complement-dependent injury of rat glomerular visceral epithelial cells.
    Camussi G, Salvidio G, Biesecker G, Brentjens J, Andres G.
    J Immunol; 1987 Nov 01; 139(9):2906-14. PubMed ID: 3312408
    [Abstract] [Full Text] [Related]

  • 15. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH, Rosenfeld SI, Jenkins DE, Thiem PA, Leddy JP.
    J Clin Invest; 1979 Aug 01; 64(2):428-33. PubMed ID: 457861
    [Abstract] [Full Text] [Related]

  • 16. Humoral immunostimulation. IV. Role of complement.
    Shearer WT, Atkinson JP, Frank MM, Parker CW.
    J Exp Med; 1975 Apr 01; 141(4):736-52. PubMed ID: 1168690
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of a disulfide-bonded peptide loop within human complement C9 in the species-selectivity of complement inhibitor CD59.
    Husler T, Lockert DH, Sims PJ.
    Biochemistry; 1996 Mar 12; 35(10):3263-9. PubMed ID: 8605162
    [Abstract] [Full Text] [Related]

  • 20. Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies.
    Helfand SC, Hank JA, Gan J, Sondel PM.
    Cell Immunol; 1996 Jan 10; 167(1):99-107. PubMed ID: 8548851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.